CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
CTSA 临床试验基础设施
基本信息
- 批准号:7961529
- 负责人:
- 金额:$ 128万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-14 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
This is the first revision of the application by the University of Florida (UF) for a CTSA. The University of Florida (UF) has a rich environment of distinguished colleges, state-of-the-art research facilities and statewide health education and health delivery systems. These resources position UF at the forefront of institutions to train the next generation of clinical and translational investigators and to help overcome two major obstacles in our nation's clinical research enterprise: the translation of basic science discoveries to early investigations in humans and the translation of clinical research into better medical practice and healthcare delivery. UF has made considerable investments dedicated exclusively to accomplish these missions. Furthermore, in direct response to the Clinical and Translational Science Award initiative, it committed substantial new research and training resources and undertook major restructuring of its traditional reporting, research and training operations to create a trans-institutional Clinical and Translational Science Institute (CTSI). The Institute will provide the new intellectual home for clinical and translational research and training at UF, integrating and synergizing the scientific and educational activities of 12 colleges, two academic and clinical campuses, two regional healthcare systems and the 67 counties ofthe State of Florida. Accordingly, this proposal sets forth the following goals to be accomplished in implementing the Institutional CTSA program: 1) Create an environment through which individuals from diverse disciplines can interact, resources, services and technologies can be identified and accessed and local and regional barriers to collaborative research can be overcome; 2) Train a workforce of clinical and basic science investigators, clinical trialists, laboratory technicians, study coordinators and other related personnel who are required to establish and support multi- and interdisciplinary clinical and translational research teams3 3) Enhance the quality and availability of cutting-edge technologies and novel research programs to accelerate the discovery, development and application of new diagnostic and therapeutic modalities; and 4) Create new opportunities for clinical scientists and the citizens of Florida to collaborate in advancing education and research into the causes, prevention, diagnosis, treatment and cure of human disease. RELEVANCE (See instructions): The proposal is relevant to the ability of UF to transform the manner by which it conducts multi- and interdisciplinary clinical and translational research and training and by which it engages the citizens across the State of Florida in community-based participatory research, education, health care and health care delivery.
该副本是利用众多研究子项目之一
由NIH/NCRR资助的中心赠款提供的资源。子弹和
调查员(PI)可能已经从其他NIH来源获得了主要资金,
因此可以在其他清晰的条目中代表。列出的机构是
对于中心,这不一定是调查员的机构。
这是佛罗里达大学(UF)对CTSA的申请进行的首次修订。佛罗里达大学(UF)拥有丰富的杰出学院,最先进的研究机构以及全州健康教育和健康提供系统的丰富环境。这些资源将UF定位在机构的最前沿,以培训下一代临床和转化调查人员,并帮助克服我们国家临床研究企业中的两个主要障碍:将基础科学发现转化为人类早期研究以及将临床研究转化为更好的医疗实践和医疗保健和医疗保健。 UF进行了大量投资,专门用于完成这些任务。此外,在对临床和转化科学奖计划的直接回应中,它具有大量的新研究和培训资源,并进行了对其传统报告,研究和培训操作进行重大重组,以创建跨机构临床和转化科学研究所(CTSI)。该研究所将为UF提供新的知识分子,用于临床和转化研究和培训,整合并协同12所学院的科学和教育活动,两个学术和临床校园,两个区域医疗保健系统以及佛罗里达州的67个县。因此,该提案阐明了实施机构CTSA计划将要实现的以下目标:1)创建一个环境,可以通过该环境来确定和访问各种学科的个人可以进行交互,可以确定资源,服务和技术,以及可以克服协作研究的本地和地区障碍; 2)培训临床和基础科学研究人员,临床试验人员,实验室技术人员,研究协调员和其他相关人员的劳动力,这些人员需要建立和支持多学科和跨学科的临床和转化研究团队3 3)提高质量和可用性,并提供了最先进的技术和新型研究计划,以加强新的研究,开发和应用新诊断,并应用了新诊断和应用诊断; 4)为临床科学家和佛罗里达州的公民创造了新的机会,以在人类疾病的原因,预防,诊断,治疗和治疗方面进行教育和研究。相关性(请参阅说明):该提案与UF转变其进行多种和跨学科的临床和转化研究和培训方式的能力有关,并通过佛罗里达州的公民参与基于社区的参与性研究,教育,医疗保健和医疗保健。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter Wallace Stacpoole其他文献
Peter Wallace Stacpoole的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter Wallace Stacpoole', 18)}}的其他基金
Personalized dosing of dichloroacetate for the treatment of rare and common diseases
二氯乙酸治疗罕见病和常见病的个性化剂量
- 批准号:
10471783 - 财政年份:2017
- 资助金额:
$ 128万 - 项目类别:
Personalized dosing of dichloroacetate for the treatment of rare and common diseases
二氯乙酸治疗罕见病和常见病的个性化剂量
- 批准号:
10216314 - 财政年份:2017
- 资助金额:
$ 128万 - 项目类别:
Personalized dosing of dichloroacetate for the treatment of rare and common diseases
二氯乙酸治疗罕见病和常见病的个性化剂量
- 批准号:
9517985 - 财政年份:2017
- 资助金额:
$ 128万 - 项目类别:
Personalized dosing of dichloroacetate for the treatment of rare and common diseases
二氯乙酸治疗罕见病和常见病的个性化剂量
- 批准号:
10010536 - 财政年份:2017
- 资助金额:
$ 128万 - 项目类别:
Phase 3 Trial of DCA in PDC Deficiency IND 028,625 (02/04/2015)
DCA 治疗 PDC 缺陷的 3 期试验 IND 028,625 (02/04/2015)
- 批准号:
10436136 - 财政年份:2016
- 资助金额:
$ 128万 - 项目类别:
Phase 3 Trial of DCA in PDC Deficiency IND 028,625 (02/04/2015)
DCA 治疗 PDC 缺陷的 3 期试验 IND 028,625 (02/04/2015)
- 批准号:
9625517 - 财政年份:2016
- 资助金额:
$ 128万 - 项目类别:
Planning Grant for Phase 3 Trial of Dichloroacetate in PDH Deficiency
二氯乙酸治疗 PDH 缺乏症第三阶段试验的规划拨款
- 批准号:
7976507 - 财政年份:2010
- 资助金额:
$ 128万 - 项目类别:
Pharmacotoxicology of Trichloroethylene Metabolites
三氯乙烯代谢物的药理学
- 批准号:
7812724 - 财政年份:2009
- 资助金额:
$ 128万 - 项目类别:
相似海外基金
North Carolina Translational and Clinical Sciences Institute (NC TraCS)
北卡罗来纳州转化与临床科学研究所 (NC TraCS)
- 批准号:
10621596 - 财政年份:2023
- 资助金额:
$ 128万 - 项目类别:
Michigan Institute for Clinical and Health Research (MICHR)
密歇根临床与健康研究所 (MICHR)
- 批准号:
10621051 - 财政年份:2023
- 资助金额:
$ 128万 - 项目类别:
Conduits: Mount Sinai Health System Translational Science Hub
管道:西奈山卫生系统转化科学中心
- 批准号:
10702195 - 财政年份:2023
- 资助金额:
$ 128万 - 项目类别:
Duke University Maternal-Fetal Medicine Units (MFMU) Network Clinical Center
杜克大学母胎医学中心 (MFMU) 网络临床中心
- 批准号:
10681052 - 财政年份:2023
- 资助金额:
$ 128万 - 项目类别: